Image

Pain Neuroscience Education Delivered During Aerobic Exercise Versus Exercise Alone

Pain Neuroscience Education Delivered During Aerobic Exercise Versus Exercise Alone

Recruiting
18-65 years
All
Phase N/A

Powered by AI

Overview

Chronic musculoskeletal pain is a common health condition that reduces quality of life and increases disability. Pain neuroscience education (PNE) has shown positive effects on pain perception, beliefs, and function, especially when combined with physical activity. This randomized controlled trial will compare the effectiveness of delivering PNE during aerobic exercise on a cycle ergometer versus aerobic exercise alone in patients with chronic musculoskeletal pain.

Participants will be randomly assigned to one of two groups:

PNE during aerobic exercise (experimental group),

Aerobic exercise alone (control group).

Both groups will perform supervised cycling sessions lasting 20-30 minutes at light intensity (Borg CR10 = 3, 40-50% HRmax). The experimental group will simultaneously receive interactive education about pain mechanisms, central sensitization, and self-management strategies, supported by visual aids and metaphors delivered by a therapist during cycling.

Outcomes will be measured at baseline and after the intervention, including:

Pain intensity (Visual Analog Scale),

Pressure pain threshold (algometry),

Functional performance (Sit-to-Stand test),

Perceived effort (Borg CR10),

Safety and comfort (Likert scale),

Muscle activity (surface EMG).

The study will enroll 28 participants (14 per group). The findings are expected to clarify whether integrating education with exercise provides superior benefits compared to exercise alone, offering an innovative, safe, and cost-effective strategy for managing chronic musculoskeletal pain.

Description

Objective To determine whether PNE delivered during cycling exercise produces greater improvements in pain intensity, pain thresholds, and functional outcomes than aerobic exercise alone.

Study Design This is a single-center, randomized controlled trial with two parallel arms (1:1 allocation). A total of 28 participants with chronic musculoskeletal pain will be recruited from the Hospital Clínico de la Universidad de Chile. Randomization will assign 14 participants to the experimental group and 14 to the control group, using the Randomization software (www.randomization.com). The random sequence will be determined prior to the start of the initial assessments and will only be known to an external research assistant with no access to participant characteristics. The assignment will remain hidden and stored in the cloud until the end of the intervention and the collection of all study data. When a participant enrolls in the study, the external research assistant will inform the therapist of the assigned intervention group.

Intervention Experimental group (PNE + exercise): 20-30 minutes of supervised cycling at light intensity (Perceived exertion, Borg CR10 = 3) while receiving interactive PNE. Education covers neurobiology of pain, central sensitization, and self-management, supported by visual aids and metaphors.

Control group (exercise alone): 20-30 minutes of supervised cycling at the same intensity (Perceived exertion, Borg CR10 = 3), without educational content.

Sample Size and Analysis Based on prior effect sizes, 28 participants (14 per group) provide sufficient power to detect moderate differences. Data will be analyzed with mixed-model ANOVA (time × group) and additional parametric or nonparametric tests as appropriate. Statistical significance is set at p < 0.05.

Ethical Considerations The study is approved by the Ethics Committee of Hospital Clínico de la Universidad de Chile. Participants will provide informed consent before participation. Risks are minimal (fatigue or mild discomfort), while expected benefits include improved pain understanding, reduced pain intensity, and improved function. This study will be conducted in accordance with the Declaration of Helsinki.

Eligibility

Inclusion Criteria:

  • Adults aged 18 to 65 years.
  • Diagnosis of chronic low back pain lasting ≥ 12 weeks.
  • Baseline pain intensity ≥ 4/10 on the Visual Analog Scale (VAS).
  • Able to perform light to moderate aerobic exercise
  • Willing and able to provide informed consent.

Exclusion Criteria:

  • Inability to understand or follow instructions.
  • Pregnancy.
  • Active cancer diagnosis.
  • Neurological disorders affecting the central nervous system (e.g., stroke).
  • Participation in alternative or concurrent therapies for pain management.
  • History of major orthopedic trauma or surgery in the last 12 months.
  • Any medical contraindication to light exercise identified during the medical screening.

Study details
    Chronic Low Back Pain

NCT07152171

University of Chile

15 October 2025

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.